(Q41433704)

30 September 2017

title

Adjuvant irradiation for early breast cancer. An on-going controversy (English)

1 reference

30 September 2017

Adjuvant irradiation for early breast cancer an on-going controversy (English)

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

8 October 2023

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

8 October 2023

author name string

J. Bedwinek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6362825

8 October 2023

language of work or name

English

0 references

publication date

1 February 1984

1 reference

full work available at URL

30 September 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819840201%2953%3A3%20%3C729%3A%3AAID-CNCR2820531322%3E3.0.CO%3B2-R

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6362825

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

8 October 2023

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

8 October 2023

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

8 October 2023

1 reference

30 September 2017

volume

53

1 reference

30 September 2017

issue

3 Suppl

1 reference

30 September 2017

page(s)

729-739

1 reference

Enlarged mastectomy for breast cancer. Review of 1,213 cases

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819840201%2953%3A3%2B%3C729%3A%3AAID-CNCR2820531322%3E3.0.CO%3B2-R

Radiotherapy as a Postoperative Surgical Adjuvant in the Management of Cancer of the Breast

21 January 2018

1

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

8 October 2023

Cancer clinical trials

4

4

229

DeLena

1981

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Analysis of failures following local treatment of isolated local-regional recurrence of breast cancer

8 October 2023

7

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial.

8 October 2023

12

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Does simple mastectomy followed by irradiation offer survival comparable to radical procedures?

8 October 2023

15

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Letter: Early breast cancer and postoperative irradiation

8 October 2023

16

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Operable cancer of the breast.A controlled clinical trial

8 October 2023

17

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

The treatment of operable cancer of the breast: A clinical trial in the South-East region of Scotland.

8 October 2023

18

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Decreased survival related to irradiation postoperatively in early operable breast cancer

8 October 2023

19

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

The effect of post-operative radiotherapy in breast cancer

8 October 2023

21

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

The value of preoperative radiotherapy in operable mammary carcinoma

8 October 2023

22

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Adjuvant radiotherapy in operable breast cancer: Correlation between dose in internal mammary nodes and prognosis

8 October 2023

23

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

A surgeon's view of the spread of breast cancer

8 October 2023

25

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study

8 October 2023

26

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers

8 October 2023

27

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Postoperative radiation therapy for “early” carcinoma of the breast

8 October 2023

30

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

The significance of the internal mammary lymph nodes in medially located breast cancer

8 October 2023

31

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Comparison of adjuvant postoperative radiotherapy and multiple-drug chemotherapy (CMF-VP) in operable breast cancer patients with more than four positive axillary lymph nodes

8 October 2023

32

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer

8 October 2023

33

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy.

8 October 2023

34

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

5-drug adjuvant chemotherapy for breast cancer

8 October 2023

35

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma

8 October 2023

36

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancer

8 October 2023

39

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer

8 October 2023

40

1 reference

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3+%3C729::AID-CNCR2820531322%3E3.0.CO;2-R

8 October 2023

Identifiers

10.1002/1097-0142(19840201)53:3+<729::AID-CNCR2820531322>3.0.CO;2-R

1 reference

30 September 2017

1 reference